| Q37198046 | 2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV. |
| Q99635253 | A Novel Peptide Antibiotic, Pro10-1D, Designed from Insect Defensin Shows Antibacterial and Anti-Inflammatory Activities in Sepsis Models |
| Q42767063 | A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression |
| Q85017485 | A novel targeted multi-functional fusion protein possesses inhibitory activities against bacteria, thrombin and platelet aggregation |
| Q43722893 | A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity |
| Q33576200 | A potential wound-healing-promoting peptide from salamander skin |
| Q40116933 | A synthetic cationic antimicrobial peptide inhibits inflammatory response and the NLRP3 inflammasome by neutralizing LPS and ATP. |
| Q52742866 | Absence of in vitro innate immunomodulation by insect-derived short proline-rich antimicrobial peptides points to direct antibacterial action in vivo. |
| Q38169955 | Activity of mesenchymal stem cells in therapies for chronic skin wound healing. |
| Q33938255 | Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications |
| Q35047135 | Additive effects of orexin B and vasoactive intestinal polypeptide on LL-37-mediated antimicrobial activities. |
| Q33737867 | Aggregation of thrombin-derived C-terminal fragments as a previously undisclosed host defense mechanism. |
| Q37404678 | Alarmins and antimicrobial immunity. |
| Q48193695 | Alarmins and immunity. |
| Q37399755 | Alarmins link neutrophils and dendritic cells |
| Q39948740 | Alveolar epithelium down-modulates endotoxin-but not tumor necrosis factor alpha-induced activation of endothelium and selectively inhibits neutrophil transendothelial migration |
| Q36321921 | Alveolar macrophage cathelicidin deficiency in severe sarcoidosis |
| Q41352131 | Amphiphilic tobramycins with immunomodulatory properties |
| Q39066110 | Anti-inflammatory Properties of Antimicrobial Peptides and Peptidomimetics: LPS and LTA Neutralization. |
| Q36214382 | Antibacterial peptides and proteins with multiple cellular targets |
| Q52655525 | Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens? |
| Q37532896 | Antimicrobial Peptides: An Emerging Category of Therapeutic Agents |
| Q33883780 | Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. |
| Q33598932 | Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37 |
| Q89927176 | Antimicrobial host defence peptides: functions and clinical potential |
| Q42275047 | Antimicrobial host defensins - specific antibiotic activities and innate defense modulation |
| Q40004678 | Antimicrobial peptide P18 inhibits inflammatory responses by LPS- but not by IFN-gamma-stimulated macrophages |
| Q36078499 | Antimicrobial peptide scolopendrasin VII, derived from the centipede Scolopendra subspinipes mutilans, stimulates macrophage chemotaxis via formyl peptide receptor 1. |
| Q38803962 | Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003-2015). |
| Q37724182 | Antimicrobial peptides and induced membrane curvature: geometry, coordination chemistry, and molecular engineering |
| Q28087327 | Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications |
| Q34684398 | Antimicrobial peptides in the oral environment: expression and function in health and disease. |
| Q37954721 | Antimicrobial peptides: key components of the innate immune system |
| Q24541575 | Antimicrobial proteins and polypeptides in pulmonary innate defence |
| Q28477585 | Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37 |
| Q27006576 | Antiviral potential of cathelicidins |
| Q40341492 | Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37. |
| Q37870295 | Avian cathelicidins: paradigms for the development of anti-infectives. |
| Q90176517 | Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability |
| Q90212729 | Bicarbonate Resensitization of Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics |
| Q57890248 | Bioactive Natural Peptides |
| Q92314534 | CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils |
| Q35777677 | Can innate immunity be enhanced to treat microbial infections? |
| Q55010741 | Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells. |
| Q54652255 | Cathelicidin Peptide LL-37 Modulates TREM-1 Expression and Inflammatory Responses to Microbial Compounds |
| Q92943132 | Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X7R/NLRP3 inflammasome |
| Q35197365 | Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis. |
| Q33700171 | Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo |
| Q26777983 | Cathelicidin impact on inflammatory cells |
| Q64052670 | Cathelicidin is a "fire alarm", generating protective NLRP3-dependent airway epithelial cell inflammatory responses during infection with Pseudomonas aeruginosa |
| Q36593572 | Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia. |
| Q36650606 | Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans |
| Q40134037 | Cathelicidins Inhibit Escherichia coli-Induced TLR2 and TLR4 Activation in a Viability-Dependent Manner |
| Q64082972 | Cathelicidins PMAP-36, LL-37 and CATH-2 are similar peptides with different modes of action |
| Q40099023 | Cathelicidins display conserved direct antiviral activity towards rhinovirus |
| Q35133502 | Cathelicidins from the bullfrog Rana catesbeiana provides novel template for peptide antibiotic design |
| Q37777020 | Cathelicidins in inflammation and tissue repair: Potential therapeutic applications for gastrointestinal disorders |
| Q58739098 | Cathelicidins: Immunomodulatory Antimicrobials |
| Q35680641 | Cationic antimicrobial peptides - an update |
| Q38022156 | Cationic host defence peptides: multifaceted role in immune modulation and inflammation. |
| Q37177085 | Cationic host defence peptides: potential as antiviral therapeutics |
| Q58590848 | Changes in salivary analytes in canine parvovirus: A high-resolution quantitative proteomic study |
| Q26998399 | Cholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and disease |
| Q33675249 | Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis. |
| Q33792343 | Comparative efficacy analysis of anti-microbial peptides, LL-37 and indolicidin upon conjugation with CNT, in human monocytes |
| Q37806640 | Contribution of neutrophils to acute lung injury |
| Q34549200 | DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells |
| Q30564789 | Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules? |
| Q38127778 | Defensins and LL-37: a review of function in the gingival epithelium |
| Q35594084 | Defensins and other antimicrobial peptides at the ocular surface |
| Q37628814 | Defensins in the oral cavity: distribution and biological role. |
| Q38201011 | Defensins: antifungal lessons from eukaryotes |
| Q91814484 | Development of a Highly Efficient Hybrid Peptide That Increases Immunomodulatory Activity Via the TLR4-Mediated Nuclear Factor-κB Signaling Pathway |
| Q92890745 | Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli |
| Q44220826 | Effect of antimicrobial peptides from Apis mellifera hemolymph and its optimized version Api88 on biological activities of human monocytes and mast cells |
| Q34367177 | Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian Dené First Nations cohort |
| Q92083684 | Effects of vitamin D supplementation on circulating concentrations of growth factors and immune-mediators in healthy women during pregnancy |
| Q36487901 | Endogenous pulmonary antibiotics |
| Q37232518 | Endotoxin, capsule, and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide LL-37. |
| Q35105947 | Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens |
| Q40061924 | Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of P. aeruginosa pneumonia |
| Q37727259 | Episodic binge ethanol exposure impairs murine macrophage infiltration and delays wound closure by promoting defects in early innate immune responses |
| Q37780272 | Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity |
| Q36098784 | Epithelial defence by gamma delta T cells |
| Q37717143 | Evaluation of the Immunomodulatory Activity of the Chicken NK-Lysin-Derived Peptide cNK-2. |
| Q34058642 | Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. |
| Q34790159 | Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils |
| Q92256576 | Expression and Function of Host Defense Peptides at Inflammation Sites |
| Q81115732 | Expression of LL-37, human beta defensin-2, and CCR6 mRNA in patients with psoriasis vulgaris |
| Q33348975 | Expression of LL-37/hCAP-18 gene in human leukemia cells |
| Q34655555 | Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells |
| Q39133003 | Expression of the antimicrobial peptide cathelicidin in myeloid cells is required for lung tumor growth |
| Q34572728 | Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide |
| Q36231828 | Function and therapeutic potential of host defence peptides. |
| Q26744224 | Functions of Cationic Host Defense Peptides in Immunity |
| Q33749859 | Generation of Novel Bone Forming Cells (Monoosteophils) from the Cathelicidin-Derived Peptide LL-37 Treated Monocytes |
| Q39903865 | Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes |
| Q62659975 | Helical antimicrobial peptides assemble into protofibril scaffolds that present ordered dsDNA to TLR9 |
| Q57821361 | High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography |
| Q36903462 | High therapeutic efficacy of Cathelicidin-WA against postweaning diarrhea via inhibiting inflammation and enhancing epithelial barrier in the intestine |
| Q37550324 | Histatin 5 binds to Porphyromonas gingivalis hemagglutinin B (HagB) and alters HagB-induced chemokine responses |
| Q41193264 | Host Antimicrobial Peptides in Bacterial Homeostasis and Pathogenesis of Disease |
| Q58785420 | Host Defense Peptide LL-37-Mediated Chemoattractant Properties, but Not Anti-Inflammatory Cytokine IL-1RA Production, Is Selectively Controlled by Cdc42 Rho GTPase G Protein-Coupled Receptors and JNK Mitogen-Activated Protein Kinase |
| Q39900346 | Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway. |
| Q34264486 | Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections |
| Q35010044 | Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? |
| Q37131510 | Host defense peptides in the oral cavity |
| Q37276479 | Host defense peptides in the oral cavity and the lung: similarities and differences |
| Q37127271 | Host defense peptides in wound healing. |
| Q54204997 | Human Metapneumovirus Infection Inhibits Cathelicidin Antimicrobial Peptide Expression in Human Macrophages. |
| Q41837033 | Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo |
| Q34758057 | Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity |
| Q47879383 | Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7. |
| Q33761299 | Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation |
| Q39496522 | Human β-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF |
| Q37505380 | Identification of Human Cathelicidin Peptide LL-37 as a Ligand for Macrophage Integrin αMβ2 (Mac-1, CD11b/CD18) that Promotes Phagocytosis by Opsonizing Bacteria. |
| Q35925429 | Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity. |
| Q43850749 | Imaging the Antistaphylococcal Activity of CATH-2: Mechanism of Attack and Regulation of Inflammatory Response. |
| Q38182446 | Immune-epithelial crosstalk at the intestinal surface |
| Q44769788 | Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis |
| Q40430371 | Immunomodulatory activities of small host defense peptides |
| Q30367948 | Immunomodulatory activity of shikimic acid and quercitin in comparison with oseltamivir (Tamiflu) in an in vitro model. |
| Q35915514 | Immunomodulatory and Anti-Inflammatory Activities of Chicken Cathelicidin-2 Derived Peptides |
| Q28257840 | Immunomodulatory properties of defensins and cathelicidins |
| Q35966461 | Impact of LL-37 on anti-infective immunity. |
| Q40139526 | Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). |
| Q38018928 | Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections |
| Q46271724 | Inhibition of curli assembly and Escherichia coli biofilm formation by the human systemic amyloid precursor transthyretin |
| Q34373912 | Innate defense regulator peptide 1018 in wound healing and wound infection |
| Q40477356 | Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. |
| Q33612504 | Interaction between the gut microbiome and mucosal immune system |
| Q28297764 | Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells |
| Q40365863 | Interspecies cathelicidin comparison reveals divergence in antimicrobial activity, TLR modulation, chemokine induction and regulation of phagocytosis |
| Q50282672 | Involvement of P2X(7) purinergic receptor and MEK1/2 in interleukin-8 up-regulation by LL-37 in human gingival fibroblasts |
| Q34952815 | LL-37 in periodontal health and disease and its susceptibility to degradation by proteinases present in gingival crevicular fluid |
| Q34341371 | LL-37 modulates human neutrophil responses to influenza A virus |
| Q38306213 | LL-37 secreted by epithelium promotes fibroblast collagen production: a potential mechanism of small airway remodeling in chronic obstructive pulmonary disease |
| Q38177267 | LPS inmobilization on porous and non-porous supports as an approach for the isolation of anti-LPS host-defense peptides. |
| Q33952458 | Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2 |
| Q37332300 | Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease |
| Q39190445 | Low concentrations of human neutrophil peptide ameliorate experimental murine colitis |
| Q34499062 | Malassezia sympodialis differently affects the expression of LL-37 in dendritic cells from atopic eczema patients and healthy individuals |
| Q39251694 | Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory |
| Q41877292 | Modulation of proinflammatory activity by the engineered cationic antimicrobial peptide WLBU-2. |
| Q35808859 | Modulation of the immune response to respiratory viruses by vitamin D. |
| Q50060087 | Modulation of toll-like receptor signaling by antimicrobial peptides |
| Q36704656 | Multifunctional antimicrobial peptides: therapeutic targets in several human diseases |
| Q37611970 | Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity |
| Q42169474 | Multiple immune-modulatory functions of cathelicidin host defense peptides. |
| Q89967217 | Murine and Human Cathelicidins Contribute Differently to Hallmarks of Mastitis Induced by Pathogenic Prototheca bovis Algae |
| Q38965476 | NAD-dependent ADP-ribosylation of the human antimicrobial and immune-modulatory peptide LL-37 by ADP-ribosyltransferase-1. |
| Q33621811 | NF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharide |
| Q35236764 | NKLP27: a teleost NK-lysin peptide that modulates immune response, induces degradation of bacterial DNA, and inhibits bacterial and viral infection |
| Q27658432 | NMR Structure of Pardaxin, a Pore-forming Antimicrobial Peptide, in Lipopolysaccharide Micelles: MECHANISM OF OUTER MEMBRANE PERMEABILIZATION |
| Q92393023 | Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications |
| Q40410408 | Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. |
| Q37248305 | Nematode Peptides with Host-Directed Anti-inflammatory Activity Rescue Caenorhabditis elegans from a Burkholderia pseudomallei Infection |
| Q34044895 | Neuroendocrine nicotinic receptor activation increases susceptibility to bacterial infections by suppressing antimicrobial peptide production |
| Q38111517 | Neutrophil roles in left ventricular remodeling following myocardial infarction. |
| Q36838556 | Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin |
| Q38093465 | Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions. |
| Q27027375 | New therapeutic approaches for treatment of tularaemia: a review |
| Q33824188 | New tricks of well-known aminoazoles in isocyanide-based multicomponent reactions and antibacterial activity of the compounds synthesized. |
| Q36941076 | Non-coding Double-stranded RNA and Antimicrobial Peptide LL-37 Induce Growth Factor Expression from Keratinocytes and Endothelial Cells |
| Q36120101 | Nuclear localization of HBD-1 in human keratinocytes |
| Q38152470 | Oral inflammation, a role for antimicrobial peptide modulation of cytokine and chemokine responses |
| Q40062395 | Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion |
| Q46237880 | P17, an Original Host Defense Peptide from Ant Venom, Promotes Antifungal Activities of Macrophages through the Induction of C-Type Lectin Receptors Dependent on LTB4-Mediated PPARγ Activation. |
| Q40631418 | Pentobra: A Potent Antibiotic with Multiple Layers of Selective Antimicrobial Mechanisms against Propionibacterium Acnes. |
| Q36538861 | Peptide antimicrobial agents |
| Q37598400 | Peptide design for antimicrobial and immunomodulatory applications |
| Q26799959 | Peptides and Peptidomimetics for Antimicrobial Drug Design |
| Q43821365 | Periodontal disease in patients from the original Kostmann family with severe congenital neutropenia |
| Q41545553 | Potential role of an antimicrobial peptide, KLK in inhibiting lipopolysaccharide-induced macrophage inflammation. |
| Q37204234 | Prevention of death in bacterium-infected mice by a synthetic antimicrobial peptide, L5, through activation of host immunity |
| Q99711445 | Probiotics at War Against Viruses: What Is Missing From the Picture? |
| Q98771311 | Promising Therapeutic Strategies Against Microbial Biofilm Challenges |
| Q64087732 | Protective Effects of Protegrin in Dextran Sodium Sulfate-Induced Murine Colitis |
| Q41474672 | Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence |
| Q36075217 | Pulmonary defense and the human cathelicidin hCAP-18/LL-37. |
| Q35101147 | Radiolabelled antimicrobial peptides for infection detection. |
| Q37526825 | Recent advances in the field of antimicrobial peptides in inflammatory diseases |
| Q38547127 | Recently disclosed chemical entities as potential candidates for management of tuberculosis |
| Q36655079 | Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism |
| Q37000779 | Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense |
| Q57177969 | Retro-inversion enhances the adjuvant and CpG co-adjuvant activity of host defence peptide Bac2A |
| Q45800178 | Role of Soluble Innate Effector Molecules in Pulmonary Defense against Fungal Pathogens |
| Q42078203 | Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis |
| Q34648068 | Salivary concentration of the antimicrobial peptide LL-37 in patients with oral lichen planus |
| Q37471134 | Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages |
| Q37875765 | Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action |
| Q35783492 | Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial |
| Q57177960 | Stability, toxicity, and biological activity of host defense peptide BMAP28 and its inversed and retro-inversed isomers |
| Q96303599 | Strategies in Translating the Therapeutic Potentials of Host Defense Peptides |
| Q38358558 | Strategies to link innate and adaptive immunity when designing vaccine adjuvants |
| Q35238104 | Synergistic anti-inflammatory activity of the antimicrobial peptides human beta-defensin-3 (hBD-3) and cathelicidin (LL-37) in a three-dimensional co-culture model of gingival epithelial cells and fibroblasts |
| Q92243227 | Synthetic Cationic Peptide IDR-1002 and Human Cathelicidin LL37 Modulate the Cell Innate Response but Differentially Impact PRRSV Replication in vitro |
| Q28548287 | The Frog Skin-Derived Antimicrobial Peptide Esculentin-1a(1-21)NH2 Promotes the Migration of Human HaCaT Keratinocytes in an EGF Receptor-Dependent Manner: A Novel Promoter of Human Skin Wound Healing? |
| Q37112412 | The New Antimicrobial Peptide SpHyastatin from the Mud Crab Scylla paramamosain with Multiple Antimicrobial Mechanisms and High Effect on Bacterial Infection |
| Q26797488 | The Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical Diseases |
| Q36465085 | The Role of Cathelicidin LL-37 in Cancer Development. |
| Q38822923 | The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease |
| Q42149510 | The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils |
| Q50786210 | The antimicrobial peptide LL37 and its truncated derivatives potentiates proinflammatory cytokine induction by lipoteichoic acid in whole blood |
| Q28244066 | The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection |
| Q36587156 | The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation |
| Q34983753 | The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. |
| Q41786720 | The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. |
| Q46018304 | The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice. |
| Q36132248 | The role of the Src family kinase Lyn in the immunomodulatory activities of cathelicidin peptide LL-37 on monocytic cells |
| Q37361213 | The roles of antimicrobial peptides in innate host defense |
| Q42205540 | The specificity of protection against cationic antimicrobial peptides by lactoferrin binding protein B. |
| Q100634478 | The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics |
| Q39062867 | The therapeutic applications of antimicrobial peptides (AMPs): a patent review |
| Q37945181 | Therapeutic approaches using host defence peptides to tackle herpes virus infections |
| Q64098572 | Thinking Outside the Bug: Molecular Targets and Strategies to Overcome Antibiotic Resistance |
| Q34629176 | Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells |
| Q52883535 | Transcriptional regulation of cathelicidin genes in chicken bone marrow cells. |
| Q34771808 | Transmembrane pores formed by human antimicrobial peptide LL-37. |
| Q42672939 | Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial |
| Q52609589 | Tryptophan-Rich and Proline-Rich Antimicrobial Peptides. |
| Q38598753 | Unique features of human cathelicidin LL-37. |
| Q21263129 | Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury |
| Q54319905 | Vitamin D status is not associated with inflammatory cytokine levels during experimental human endotoxaemia. |
| Q42779097 | Vitamin D-mediated induction of innate immunity in gingival epithelial cells |
| Q82953601 | Vitamin D3 and the immune system: maintaining the balance in health and disease |
| Q50957903 | What is the role of antimicrobial peptides (AMP) in acne vulgaris? |
| Q37996291 | β-Defensins: multifunctional modulators of infection, inflammation and more? |